Evidence map›Paper›PMID 40906397›Full record

ReviewScience progress

Adenosarcoma of uterus characterized by differentiation of rhabdomyosarcoma and chondrosarcoma: A case report and review of literature.

Guorong Yang, Yongxin Lu, Yongdong An, Xiaoxia He, Dunhui Ma, Li Jiao, Yankun Li

Abstract readCase ReportsReview
In one paragraph

Review in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guorong YangDepartment of Pathology, San Ai Tang Hospital, Lanzhou, China.ORCID 0009-0003-4415-2508
Yongxin LuDepartment of Pathology, San Ai Tang Hospital, Lanzhou, China.ORCID 0009-0006-6208-8652
Yongdong AnDepartment of Pathology, The People's Hospital of Linxia Hui Autonomous Prefecture, Linxia, China.ORCID 0009-0009-4343-1066
Xiaoxia HeDepartment of Oncology, The Second People's Hospital of Lanzhou, Lanzhou, China.ORCID 0009-0005-3088-7591
Dunhui MaDepartment of Pathology, San Ai Tang Hospital, Lanzhou, China.ORCID 0009-0002-8152-3884
Li JiaoDepartment of Pathology, San Ai Tang Hospital, Lanzhou, China.ORCID 0009-0005-7747-177X
Yankun LiDepartment of Pathology, San Ai Tang Hospital, Lanzhou, China.ORCID 0009-0007-6568-0587

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although Müllerian adenosarcoma of the uterus shows weak malignant potential, there are still some factors indicating a worse prognosis. An incontinuous pelvic pain with urinary frequency, urgency, and hypouricemia arose in a mid-70s woman who refused to acknowledge the history of Tamoxifen use. A huge mass in the pelvis was found simultaneously by palpation, B-ultrasonography, and computed tomography. After a total hysterectomy was performed, a mass with a size of 10.5 cm × 8.5 cm × 8.5 cm was seen at the fundus of the uterus. The tumor consisted of a few benign epithelia and the majority of sarcomas, which mainly contained rhabdomyosarcoma and chondrosarcoma, and a small proportion of endometrial stromal sarcoma. Multifocal necrosis was noticed while the superficial muscular layer of the uterus was invaded. So Müllerian adenosarcoma of the uterus was given to the patient. Eight months after the operation, the patient died from respiratory failure due to pulmonary metastasis. It is suggested that sarcomatous overgrowth, the presence of heterologous elements, especially rhabdomyosarcoma and chondrosarcomatous, myoinvasion, and necrosis, may be histological factors indicating an adverse prognosis.

Indexed as

AdenosarcomaChondrosarcomaRhabdomyosarcomaUterine NeoplasmsAgedCell DifferentiationFatal OutcomeFemaleHumanscase reportchondrosarcomaMüllerian adenosarcomarhabdomyosarcomaUterus

Identifiers

PMID40906397
PMCPMC12411721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.